Corebridge Financial Reports Strong Growth in Q4 2025 Earnings Call
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy CRBD?
Source: seekingalpha
- Strong Performance: Corebridge achieved a 4% year-over-year increase in earnings per share in 2025, with return on equity up 20 basis points and capital returned to shareholders rising 13%, indicating robust market performance and enhanced profitability.
- Product Innovation: The newly launched MarketLock RILA product quickly entered the top 10 providers and is now available through over 200 distribution partners, with expectations for continued sales growth in 2026, further solidifying its market position.
- Capital Flexibility: Institutional Markets sales grew by 24%, driven primarily by pension risk transfers and guaranteed investment contracts, demonstrating the company's flexibility in capital allocation and positive outlook for future earnings growth.
- Dividend Increase: The board approved a 4% increase in the dividend to $0.25 per share, reflecting confidence in future profitability while providing higher returns to shareholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CRBD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CRBD
Wall Street analysts forecast CRBD stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 24.370
Low
Averages
High
Current: 24.370
Low
Averages
High

No data
About CRBD
Corebridge Financial, Inc. is a provider of retirement solutions and insurance products in the United States. The Company partners with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. The Company’s Individual Retirement segment consists of fixed annuities, fixed index annuities, variable annuities, and retail mutual funds. Its Group Retirement segment consists of record-keeping, plan administrative and compliance services, financial planning and advisory solutions offered in-plan, along with proprietary and limited non-proprietary annuities, advisory and brokerage products offered out-of-plan. Its Life Insurance segment includes products in the United States, including term life and universal life insurance. Its Institutional Markets segment consists of stable value wrap (SVW) products, structured settlement, and pension risk transfer (PRT) annuities, corporate markets products and guaranteed investment contracts (GICs).
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strong Performance: Corebridge achieved a 4% year-over-year increase in earnings per share in 2025, with return on equity up 20 basis points and capital returned to shareholders rising 13%, indicating robust market performance and enhanced profitability.
- Product Innovation: The newly launched MarketLock RILA product quickly entered the top 10 providers and is now available through over 200 distribution partners, with expectations for continued sales growth in 2026, further solidifying its market position.
- Capital Flexibility: Institutional Markets sales grew by 24%, driven primarily by pension risk transfers and guaranteed investment contracts, demonstrating the company's flexibility in capital allocation and positive outlook for future earnings growth.
- Dividend Increase: The board approved a 4% increase in the dividend to $0.25 per share, reflecting confidence in future profitability while providing higher returns to shareholders.
See More

Management Performance: Corebridge Financial reported Q1 2025 operating EPS of $1.16 and a return on equity of 11.8%, with a focus on organic growth and capital management, despite challenges from market volatility and Federal Reserve rate actions.
Financial Outlook: The company aims for long-term EPS growth of 10%-15% and anticipates a 5%-10% increase in dividends from insurance subsidiaries in 2025, while addressing concerns over rising surrender rates and alternative investment returns.
See More




